tiprankstipranks
Alnylam Pharmaceuticals announces interim Phase 1 data of nucresiran
PremiumThe FlyAlnylam Pharmaceuticals announces interim Phase 1 data of nucresiran
2M ago
BridgeBio price target raised to $45 from $44 at Scotiabank
Premium
The Fly
BridgeBio price target raised to $45 from $44 at Scotiabank
2M ago
Alnylam cut to Underperform at Wolfe Research amid Amvuttra expansion
Premium
The Fly
Alnylam cut to Underperform at Wolfe Research amid Amvuttra expansion
2M ago
U.S. drugmakers shifting away from Chinese supply-chain partners, WSJ says
PremiumThe FlyU.S. drugmakers shifting away from Chinese supply-chain partners, WSJ says
3M ago
Alnylam price target raised to $329 from $295 at Barclays
Premium
The Fly
Alnylam price target raised to $329 from $295 at Barclays
3M ago
Alnylam Pharmaceuticals Reports Mixed Quarterly Earnings
Premium
Company Announcements
Alnylam Pharmaceuticals Reports Mixed Quarterly Earnings
3M ago
Disney initiated, Cisco upgraded: Wall Street’s top analyst calls
PremiumThe FlyDisney initiated, Cisco upgraded: Wall Street’s top analyst calls
3M ago
Alnylam submits regulatory application to EMA for vutrisiran for ATTR-CM
Premium
The Fly
Alnylam submits regulatory application to EMA for vutrisiran for ATTR-CM
3M ago
Alnylam initiated with an Outperform at Scotiabank
Premium
The Fly
Alnylam initiated with an Outperform at Scotiabank
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100